Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Ghasparian, A"'
Autor:
Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle, John A. Robinson, Arin Ghasparian
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
Abstract Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of ep
Externí odkaz:
https://doaj.org/article/adb559966dc64ff4b26148413e229c01
Autor:
Armando Zuniga, Oliver Rassek, Melissa Vrohlings, Aniebrys Marrero-Nodarse, Kerstin Moehle, John A. Robinson, Arin Ghasparian
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/7f3d6229caa145df9f6891d454e2fa99
Autor:
Marco Tamborrini, Nina Geib, Aniebrys Marrero-Nodarse, Maja Jud, Julia Hauser, Celestine Aho, Araceli Lamelas, Armando Zuniga, Gerd Pluschke, Arin Ghasparian, John A. Robinson
Publikováno v:
Vaccines, Vol 3, Iss 4, Pp 850-874 (2015)
Alternatives to the well-established capsular polysaccharide-based vaccines against Streptococcus pneumoniae that circumvent limitations arising from limited serotype coverage and the emergence of resistance due to capsule switching (serotype replace
Externí odkaz:
https://doaj.org/article/bd3ac40b3b114e489cb401e7e801ed34
Autor:
Aniebrys Marrero-Nodarse, Kerstin Moehle, Melissa Vrohlings, Oliver Rassek, John A. Robinson, Arin Ghasparian, Armando Zuniga
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
NPJ Vaccines
NPJ Vaccines
Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes ta
Autor:
Aniebrys Marrero-Nodarse, Oliver Rassek, Kerstin Moehle, Arin Ghasparian, Armando Zuniga, John A. Robinson, Melissa Vrohlings
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-1 (2021)
npj Vaccines, Vol 6, Iss 1, Pp 1-1 (2021)
Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly. However, attempts to develop a safe and effective vaccine have so far been unsuccessful. Atomic-level structures of epitopes ta
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paul-Henri Lambert, Pierre-Louis Hervé, Oliver Rassek, Hugh A. Sampson, Arin Ghasparian, Nathalie Donne, Armando Zuniga, Pierre-Henri Benhamou, Kevin C. Yim, Lucie Mondoulet, Véronique Dhelft
Publikováno v:
Vaccine. 39(32)
Despite the substantial health and economic burden caused by RSV-associated illness, no vaccine is available. The sole licensed treatment (palivizumab), composed of a monoclonal neutralizing antibody, blocks the fusion of the virus to the host cell b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43248 (2012)
DC employ several endocytic routes for processing antigens, driving forward adaptive immunity. Recent advances in synthetic biology have created small (20-30 nm) virus-like particles based on lipopeptides containing a virus-derived coiled coil sequen
Externí odkaz:
https://doaj.org/article/0bcf0f7b35514432b4102224627a6079
Publikováno v:
The Journal of Immunology. 199:734-749
Dendritic cells (DCs) play critical roles in developing immune defenses. One important aspect is interaction with pathogen-associated molecular patterns (PAMPs)/danger-associated molecular patterns, including di- and triacylated lipopeptides. Isolate